Designing and implementing methodology for double-blind, placebo-controlled clinical trials using blood products within the Department of Veterans Affairs.

Miller, Elliott K; Goldberg, Alexa M; Janoff, Edward N; Brown, Sheldon T; Curtis, Jeffrey L; Bonomo, Robert A; Shih, Mei-Chiung; Gleason, Theresa C

Miller, Elliott K; Goldberg, Alexa M; Janoff, Edward N; Brown, Sheldon T; Curtis, Jeffrey L; Bonomo, Robert A; Shih, Mei-Chiung; Gleason, Theresa C.

Afiliación

Miller EK; Department of Veterans Affairs, Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA.
Goldberg AM; Department of Veterans Affairs, Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA.
Janoff EN; Rocky Mountain Regional VA Medical Center, Aurora, CO, USA.
Brown ST; University of Colorado Denver School of Medicine, Aurora, CO, USA.
Curtis JL; James J. Peters Department of Veterans Affairs Medical Center, Bronx, NY, USA.
Bonomo RA; VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Shih MC; University of Michigan Medical School, Ann Arbor, MI, USA.
Gleason TC; Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA.

Clin Trials ; 19(2): 137-145, 2022 04.

Article en En | MEDLINE | ID: mdl-35229691

Asunto(s)

COVID-19; Veteranos; COVID-19/terapia; Humanos; Inmunización Pasiva; Pandemias; Preparaciones Farmacéuticas; SARS-CoV-2; Resultado del Tratamiento; Sueroterapia para COVID-19

Palabras clave

Blinding procedures; COVID-19; COVID-19 convalescent plasma; VA CURES-1; Veterans Affairs; blood bank services; blood product; investigational drug services; randomized clinical trial

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Veteranos / COVID-19 Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google